DIN 02543451 — KALYDECO 13.4 MG
KALYDECO is a granules of Ivacaftor marketed by VERTEX PHARMACEUTICALS (CANADA) INCORPORATED. The full Ivacaftor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02543451
- Brand name
- KALYDECO
- Active ingredient
- Ivacaftor
- Strength
- 13.4 MG
- Dosage form
- GRANULES
- Route
- ORAL
- Manufacturer
- VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- CFTR potentiator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ivacaftor products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02397412 | KALYDECO | 150 MG | TABLET | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02519364 | KALYDECO | 25 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02442612 | KALYDECO | 50 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02442620 | KALYDECO | 75 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |